Mechanisms of fever induced by recombinant human interferon.
暂无分享,去创建一个
N. C. Hamilton | G W Duff | C. Dinarello | H. Bernheim | G. Duff | F. Coceani | C A Dinarello | H. Le | H A Bernheim | H V Le | T L Nagabhushan | N C Hamilton | F Coceani | T. L. Nagabhushan | Harry A. Bemheim | Flavio Coceanl
[1] K. Cantell,et al. Side effects of long-term treatment with human leukocyte interferon. , 1979, The Journal of infectious diseases.
[2] V. As,et al. Further studies on the antipyretic action of polymyxin B in pyrogen-induced fever. , 1978 .
[3] C. Dinarello,et al. Demonstration of a circulating suppressor factor of thymocyte proliferation during endotoxin fever in humans. , 1981, Journal of immunology.
[4] S. Kohl. Stimulation of human natural killer cytotoxicity and protection of mice from infection due to herpes simplex virus by recombinant human leukocyte interferon. , 1983, The Journal of infectious diseases.
[5] R. Hornick,et al. Mechanisms of endotoxin tolerance with special reference to man. , 1973, The Journal of infectious diseases.
[6] Bocci Vu. Possible causes of fever after interferon administration. , 1980 .
[7] F. Audibert,et al. Properties of reference Escherichia coli endotoxin and its phthalylated derivative in humans. , 1981, The Journal of infectious diseases.
[8] P. K. Dey,et al. Lipid A fever in cats. , 1975, The Journal of physiology.
[9] S. Fineberg,et al. Development of IgE Antibodies to Human (recombinant DNA), Porcine, and Bovine Insulins in Diabetic Subjects , 1982, Diabetes Care.
[10] C. Dinarello. Demonstration of a human pyrogen-inducing factor during mixed leukocyte reactions , 1981, The Journal of experimental medicine.
[11] C. Dinarello,et al. DEMONSTRATION AND CHARACTERIZATION OF TWO DISTINCT HUMAN LEUKOCYTIC PYROGENS , 1974, The Journal of experimental medicine.
[12] C. Dinarello,et al. Prostaglandin E2 and thromboxane B2 in cerebrospinal fluid of afebrile and febrile cat. , 1983, The American journal of physiology.
[13] T. Merigan,et al. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. , 1982, Annals of internal medicine.
[14] H. Bernheim,et al. Fever: pathogenesis, pathophysiology, and purpose. , 1979, Annals of internal medicine.
[15] G. Duff,et al. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. , 1982, Journal of immunological methods.
[16] F. Arenzana‐Seisdedos,et al. Interferons as macrophage‐activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide‐stimulated human monocytes , 1983, European journal of immunology.
[17] J. Dunnick,et al. Update on Clinical Trials with Exogenous Interferon , 1980 .
[18] J. Stitt,et al. Prostaglandin E levels in third ventricular cerebrospinal fluid of rabbits during fever and changes in body temperature , 1980, The Journal of physiology.
[19] C. Dinarello,et al. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide. , 1980, The Journal of infectious diseases.
[20] R. Hornick,et al. Comparative Pyrogenic Reactivity of Rabbit and Man to Bacterial Endotoxin∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[21] C. Dinarello,et al. Ability of Human Leukocytic Pyrogen to Stimulate Brain Prostaglandin Synthesis In Vitro , 1982, Journal of neurochemistry.
[22] J. Maclouf,et al. Radioimmunoassay of Prostaglandins Fα, E1 and E2 in Human Plasma , 1975 .
[23] C. Dinarello,et al. Human leukocytic pyrogen: purification and development of a radioimmunoassay. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[24] A. Fontana,et al. Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. , 1982, Journal of immunology.
[25] E. Atkins. Pathogenesis of fever. , 1960, Physiological reviews.
[26] S. Wolff. Biological effects of bacterial endotoxins in man. , 1973, The Journal of infectious diseases.
[27] G. Duff,et al. The detection of endotoxin by in vitro production of endogenous pyrogen: comparison with limulus amebocyte lysate gelation. , 1982, Journal of immunological methods.
[28] F. Fitzpatrick,et al. Virus and interferon effects on cellular prostaglandin biosynthesis. , 1980, Journal of immunology.
[29] A. Billiau. Pharmacokinetic and pharmacological aspects of interferon therapy in man. , 1981, Acta microbiologica Academiae Scientiarum Hungaricae.
[30] S. Wolff,et al. QUANTITATIVE ASPECTS OF THE PYROGENIC RESPONSE OF RABBITS TO ENDOTOXIN. , 1965, The Journal of laboratory and clinical medicine.
[31] J. Dunnick,et al. Clinical trials with exogenous interferon: summary of a meeting. , 1979, The Journal of infectious diseases.
[32] H. Prange,et al. Intrathecal use of interferon in encephalitis. , 1981, The New England journal of medicine.
[33] T. Merigan,et al. Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer. , 1982, JAMA.
[34] A. Goldberg,et al. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. , 1983, The New England journal of medicine.
[35] K.,et al. Genetic control of endotoxic responses in mice , 1978, The Journal of experimental medicine.
[36] D. Alling,et al. COMPARISON OF HEMATOLOGIC AND FEBRILE RESPONSE TO ENDOTOXIN IN MAN. , 1965, Blood.